Scientists explore structure of SARS-CoV-2 receptor-binding domain with G485R mutation
The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread globally, with […]
The heterogeneous coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in Wuhan, […] Nanomedicine is a very powerful tool with the potential to mitigate the burden of disease by providing nanoparticle-based carriers and […] Researchers at the University of Alabama at Birmingham have identified a new molecular target that could potentially treat the deadly, […] COVID-19 (coronavirus disease 2019) is caused by a new positive-strand RNA coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), […] A team of scientists in Israel recently evaluated the efficacy of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine, BNT162b2 (also […] The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement for […] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the coronavirus disease 2019 (COVID-19) pandemic. To date, […] Researchers have pinpointed a helper T cell population in the lungs of patients with severe COVID-19 that may be central […] Researchers in the United States and Canada have conducted a study showing that just a single dose of either the […]respiratory
Living with a COVID-19 case brings worse symptoms and stronger antibody response
The role of nanotechnology in the fight against COVID-19
Researchers discover new molecular target that could treat idiopathic pulmonary fibrosis
Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2
Data from Israel’s vaccination program suggests Pizer-BioNTech COVID-19 vaccine induces strong host antibody response
In-licensed candidate may be an effective intervention for preterm infants with respiratory distress syndrome
Corticosteroid receptor inhibitor shows anti-SARS-CoV-2 activity in vivo
Hyperactive immune system contributes to COVID-19 severity, lung damage
Both mRNA vaccines protect against emerging variants of SARS-CoV-2